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ABSTRACT We have exmined the effect of a synthetic
analogue of human et-atrial natriuretic peptide (ANP), APH,
on renin release in cultured renal juxtaglomerular cells (JGA
cells). Using cell cultures containing 80-90% renal juxtaglom-
erular cells, we found that ANP (10-13-10-9 M) strongly
inhibited renin release from the cells in a dose-dependent
fashion (ki, 10 pM) to about 10% of control. Inhibition of renin
release by ANP was paralleled by an increase in cellular cGMP
levels; while in the presence of the cGMP-phosphodiesterase
inhibitor M&B 22948 (1 mM), concentrations ofANP lower by
a factor of 100 were required to obtain the same effects on renin
release and cGMP levels. The guanylate cyclase inhibitor
methylene blue (10 IAM), on the other hand, shifted the
dose-response curves for renin release and cGMP levels to
100-fold higher concentrations of ANP. Neither the influx of
45Ca into the cells nor the intracellular quin-2 signal, which is
a measure for changes of intracellular Ca concentration, was in
any way altered by ANP. Our results suggest that ANP inhibits
renin release fromjuxtaglomerular cells by a cGMP-dependent
process that does not involve changes in intracellular calcium.
Two major effects of atrial natriuretic peptide (ANP) on renal
function have been described, namely the enhancement of
sodium and water excretion (cf. refs. 1 and 2) and the
suppression of renin release (3-5). Inhibition of renin release
by ANP leading to a diminished formation of angiotensin II
(AI) would result in decreased vascular tone and impaired
aldosterone secretion. Both effects are of physiological
importance during states of expanded extracellular volume,
in which enhanced release of ANP from the atrium is
observed (6, 7).
The mechanism by which ANP inhibits renal renin release
is as yet a matter of debate (2). In view of the increased
filtration rate of NaCl caused by the ANP, which leads to an
increased NaCl load at the macula densa, it has been
speculated that ANP inhibits renin release fromjuxtaglomer-
ular cells via the macula densa receptor (3, 4). However, a
direct effect of ANP on juxtaglomerular cells could not be
excluded on the basis of experimental evidence. Therefore,
we wanted to investigate whether or not ANP directly
inhibits renin release by renal juxtaglomerular cells.
We have developed a cell culture system that contains
around 50% juxtaglomerular cells (8, 9). We now have
improved this method by including a Percoll-density gradient
in the cell preparation procedure. As a result, cell cultures
can be obtained that contain regularly between 80 and 90%juxtaglomerular cells.
We found that ANP strongly inhibits renin release from
these cultured cells and, furthermore, obtained strong evi-
dence that the inhibitory effect ofANP is mediated by cGMP
and does not involve an increase in intracellular calcium.
MATERIALS AND METHODS
Cell Culture. Isolation ofjuxtaglomerular cells was essen-
tially as described (8, 9). In brief, rat kidneys were perfused
in situ with citrate buffer. After exstirpation of the kidneys,
renal cortex was minced and subsequently incubated with a
collagenase-trypsin solution. The suspension was poured
over a 22-ptm screen, and single cells passing the sieve were
washed with culture medium. As described (9), cell cultures
containing about 50% juxtaglomerular cells can be obtained
by culturing these single cells. To improve the enrichment ofjuxtaglomerular cells, we centrifuged the cells in a Percoll-
density gradient. About 15 x 106 cells were mixed with 30 ml
of an isotonic 25% (vol/vol) Percoll solution and centrifuged
at 15,000 x g in a vertical rotor (SV-288, Sorvall) for 30 min.
Four different bands with densities of 1.02 g/ml, 1.05 g/ml,
1.06 g/ml, and 1.13 g/ml were regularly obtained. Table 1
gives typical values for the distribution ofprotein and specific
renin activity within the gradient. Band III cells (1.06 g/ml)
were incubated with culture medium [RPMI 1640, 25 mM
Hepes, streptomycin at 100 tug/ml, penicillin at 100 units/ml,
2% (vol/vol) fetal bovine serum] at 370C in 5% C02/95% air.
All experiments as described below were performed on the
second day of culture.
Renin Demonstration by Immunofluorescence. Immuno-
fluorescence staining for renin was done exactly as described
(9). In brief, cell cultures were fixed in 4% (wt/vol)
paraformaldehyde/Dulbecco's phosphate-buffered saline
(PBS). After 5 min in 10% (vol/vol) normal swine
serum/0.1% bovine serum albumin/PBS, the cultures were
incubated with rabbit antiserum against rat renin diluted
1:200 in 10% (vol/vol) normal swine serum/PBS. After
rinsing in PBS, a 30-min incubation followed with tetra-
methylrhodamine B isothiocyanate (TRITC)-conjugated goat
anti-rabbit IgG (1:500, Sigma). The specificity of the im-
munoreaction was tested with the usual control procedures
(9). Immunofluorescence was examined using a Polyvar
fluorescence microscope (Reichert-Jung, Vienna, Austria).
Rabbit antiserum against rat renin, used in the studies, was
a generous gift of M. Celio (Zurich) who obtained it from T.
Inagami (Nashville, TN). For immunocytochemical demon-
stration and localization with the protein A/gold technique,
pellets of 106 cells were fixed in 1% glutaraldehyde and
embedded in London White resin (London Resin, Basing-
stoke, England). Ultrathin sections were immunostained for
renin as described by Taugner et al. (10). Rabbit antiserum
against rat renin used in these studies was a generous gift
from E. Hackenthal.
Renin Release. Renin release from the cultured cells was
determined exactly as described (8). In brief, the culture
medium was replaced with prewarmed, Hepes-buffered sa-
line [132 mM NaCl, 5 mM KCl, 0.8 mM MgSO4, 2 mM CaCl2,
Abbreviations: ANP, atrial natriuretic peptide; Al, angiotensin I;
All, angiotension II; [Ca]j, intracellular Ca2+ concentration.
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Table 1. Protein distribution and specific renin activity of cells
separated by a 25% (vol/vol) Percoll gradient
Specific renin activity,
Density, Protein, ng of AI per hr
Band g/ml mg per mg of protein
I 1.02 2.01 ± 0.35 30 ± 11
II 1.05 3.36 ± 0.75 143 ± 60
III 1.06 0.51 ± 0.19 1170 ± 280
IV 1.13 3.27 ± 0.62 7 ± 5
Data are mean ± SEM of three experiments.
10 mM NaOAc, 2 mM NaH2PO4, 10 mM glucose, 20 mM
Hepes (pH 7.2)]; and the culture dishes were placed on a
heating block at 370C. The renin secretion rate was calculated
from the linear increase of the renin activity of the cell-
conditioned buffer before and 10, 20, and 30 min after
addition of the agents.
Renin Activity Assay. Renin activity was determined by its
ability to generate angiotensin I (AI) from the plasma of
bilaterally nephrectomized rats exactly as described (11). AI
was determined by radioimmunoassay (Isotopen Dienst
West, Teufen, Switzerland).
Intracellular cGMP Levels. Intracellular cGMP concentra-
tions were examined under the same experimental conditions
as the renin release. Five minutes after the addition of the
agents, the buffer was removed from the cultures, and the
dishes were placed on an ice block. After the addition of 0.4
ml of ice-cold 5 mM potassium phosphate, 0.2 mM EDTA,
0.5 mM 3-isobutyl-methylxanthine, and 150 mM KCl (pH
6.8), the cells were scraped off with a Teflon policeman. The
cell suspension so obtained was sonicated, boiled for 5 min,
and centrifuged. An aliquot was removed from the sonicated
cell suspension for protein determination. The supernatants
were assayed for cGMP using a cGMP radioimmunoassay
(New England Nuclear).
45Ca-Uptake. 45Ca-uptake into the cultured cells was de-
termined exactly as described (8).
Intracellular Ca2' Measurement. Intracellular Ca2+, [Ca]i,
was measured using quin-2. About 2 x 107 cells were
incubated with 25 uM quin-2 AM [tetrakis(acetoxymethyl)
ester of quin-2] in RPMI 1640 for 20 min followed by another
40-min incubation with 4 vol of medium. After the incubation
period, aliquots of 1 x 106 cells were washed twice and
resuspended in Hepes-buffered saline. Fluorescence of quin-
2-loaded cells was measured at 37°C in a Perkin-Elmer
fluorescence spectrophotometer L93 using excitation wave-
length of 340 nm and emission wavelength of 490 nm. The
fluorescence signal was calibrated at the end of each indi-
vidual trace essentially as described by Tsien et al. (12). Cell
numbers were determined using a Coulter counter. Protein
was determined according to the method of Lowry (13) with
bovine serum albumin as a standard.
Reagents. All reagents for the culture medium were ob-
tained from Boehringer Mannheim. Synthetic atrial peptide
(Arg-101 to Tyr-126) was a generous gift from F. Spinelli
(CIBA-Geigy, Basel, Switzerland). The cGMP-specific
phosphodiesterase inhibitor M&B 22948 was kindly provided
by the May & Baker Company (Dagenham, Essex, U.K.).
Sodium nitroprusside, methylene blue, and AII were pur-
chased from Sigma. 45Ca was from Amersham (U.K.). Quin-2
AM was obtained from Calbiochem.
RESULTS
Cell Culture. Fig. 1 (Upper) Phase-contrast photomicro-
graph of Band III cells cultured for 2 days. The cultures
consisted of80-90% round, single cells. These cells exhibited
specific immunofluorescence for renin (Fig. 1, Lower). As we
FIG. 1. Microphotograph of cultured cells on second day of
culture. (Upper) Phase-contrast and (Lower) immunofluorescence
micrographs of cells treated with rabbit anti-rat renin and TRITC-
labeled goat anti-rabbit y-globulin. (x2902.)
have also shown elsewhere (9), the round cells that stain for
renin contain prominent renin granules (Fig. 2). We, there-
fore, conclude that these cells are juxtaglomerular cells. The
cellular renin activity of the cultured cells used in this study
was between 100-200 ng ofAl per hr per mg ofprotein on the
second day of culture. The renin activity in the culture
medium was between 1 and 2.6 ,g of AI per hr per mg of
cellular protein.
Effect ofANP on the Cultured Cells. Fig. 3 shows the effect
of ANP on the spontaneous renin release from the cultured
cells. It can be seen that ANP strongly inhibited renin release
in a dose-dependent fashion between 10-13 and 10-9 M. In
parallel with the inhibition of renin release, ANP led to an
increase in intracellular cGMP levels (Fig. 4). To find out
whether or not the inhibitory effect ofANP on renin release
is causally linked to the increase in intracellular cGMP, we
examined the effects of ANP on renin release and cGMP
levels in presence of the cGMP phosphodiesterase inhibitor
M&B 22948 (14) and the guanylate cyclase inhibitor methyl-
ene blue (15). Fig. 4 shows that M&B 22948 (1 mM) shifted
the dose-response curves for renin release and cGMP levels
to concentrations ofANP lower by a factor of 100. Methylene
blue (10 ,uM) on the other hand decreased the ANP sensitivity
of renin release and cGMP levels ofjuxtaglomerular cells by
a factor of 100. Nitroprusside also elevates intracellular
cGMP levels by stimulating soluble guanylate cyclase (14,
16). We, therefore, tested the effect of sodium nitroprusside
on renin release and cGMP levels of the cultured juxtaglom-
erular cells. We found that 1 ,iM sodium nitroprusside
decreased renin release to 54 ± 10% of control (n = 5) and
elevated cGMP levels to 154 ± 9% of control (n = 5).
Because there is strong evidence that an increase in the
intracellular calcium concentration is an inhibitory signal for
renin release from juxtaglomerular cells (8, 17, 18), we
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FIG. 2. Electron micrograph of isolated epitheloid cells with mature secretory granules labeled with antiserum against rat renin. All granules
are intensely'tlabeled.(x 15,800.)
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FIG. 3. ANP concentration dependence of renin-releasing rate FIG. 4. ANP concentration dependence ofcellular cGMP content
from the cultured cells. ANP alone (o) or ANP in the presence of 1 of the cultured cells. ANP alone (o) or ANP in the presence of 1 mM
mM M&B 22948 (o) or in the presence of 10 AiM methylene blue (A). M&B 22948 (m) or in the presence of 10 ,uM methylene blue (A). Data
Data are mean ± SEM of 10 experiments. are mean ± SEM of six experiments.
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wanted to find out whether or not ANP influences calcium
metabolism in cultured juxtaglomerular cells. We, therefore,
studied the effect of ANP on the influx of 45Ca2" into cells.
The data shown in Table 2 provide strong evidence that ANP
(0.1 nM) does not stimulate calcium influx into the cells. AII
(0.1 ,uM) on the other hand, which was used as control,
significantly increased calcium influx. We, furthermore,
examined the effect of ANP on [Ca]i as monitored by the
quin-2 signal. Fig. 5 shows one typical recording out of five.
In no instance did ANP (0.1 nM) alter the quin-2 signal, while
AII (0.1 AuM) regularly increased [Ca]i to 126 ± 3% of control(n = 5).
DISCUSSION
There is evidence to indicate that ANP inhibits renal renin
release (3-5). Since the mechanism of this inhibitory effect is
unclear, the present study examined whether or not ANP
acted directly on juxtaglomerular cells and if so which
intracellular events mediated the inhibition of renin release.
For our study we used cell cultures containing 80-90%o cells
that stained positive for renin (Fig. 1) and that contained
prominent renin granules (Fig. 2). Sincejuxtaglomerular cells
are the only renal cells that have these two characteristics, we
infer from our results that the cells we used in the present
culture originate from juxtaglomerular cells.
We found that synthetic ANP, identical to human a-ANP
(19), strongly inhibited renin release from thejuxtaglomerular
cells (Fig. 3). Half-maximal inhibition could be observed at 10
pM ANP. It is noteworthy in this context that the normal
plasma concentration ofANP is around 10pM in humans and
rats (6, 7, 20, 21).
During volume expansion ANP levels were found to
increase up to 0.1 nM (6, 7). It appears, therefore, that the
concentration range in which the ANP can be physiologically
varied is well within the concentrations at which we observed
inhibition of renin release (Fig. 3). Therefore, ANP is likely
to have a physiologically regulatory function on renin release
from the kidney. Moreover, it has been shown that half-
maximal inhibition of aldosterone secretion from adrenal
cells by ANP is observed at 20 pM ANP (22). This figure is
very close to the results obtained in this study.
We have obtained three pieces of evidence for a causal link
between cGMP and inhibition of renin release by ANP. ()
ANP elevates cGMP levels, and this effect parallels the
inhibition of renin release (Fig. 4). (ii) Inhibition of the
cGMP-specific phosphodiesterase (by M&B 22948) leads to
an apparent increase of the ANP sensitivity ofjuxtaglomer-
ular cells for the inhibition of renin release and increase of
cGMP levels. Inhibition of guanylate cyclase by methylene
blue on the other hand lowers the ANP sensitivity of
juxtaglomerular cells for renin release and increase in cGMP
levels (Fig. 3). (iii) Sodium nitroprusside, which is known to
increase cGMP levels in muscle tissues by activating gua-
nylate cyclase (23), also elevated cGMP levels in the juxta-
glomerular cells and simultaneously inhibited renin release.
Fig. 6 shows a plot of renin releasing rate vs. intracellular
cGMP levels as a function of ANP in the absence and
presence of M&B 22948, methylene blue, and sodium
Table 2. Effects of 0.1 nM ANP and 0.1 ILM AII on 45Ca uptake
into cultured juxtaglomerular cells
Rate of 45Ca uptake, cpm per mg of protein
30 sec 60 sec 120 sec
4
x
3
U 2
ANP t AIlt
2 min
FIG. 5. Quin-2 fluorescence of the cultured cells after addition of
synthetic 100 pM ANP and 100 nM AII. [Ca2+]i is on a logarithmic
scale. Arrows indicate addition of agents.
nitroprusside. It is evident that the data for cGMP levels and
renin-releasing rate fall on the same curve under all condi-
tions tested. This may be taken as a further indication of a
causal role for cGMP in the inhibition of renin release from
juxtaglomerular cells. It is noteworthy in this connection that
a stimulation of particulate guanylate cyclase by atrial natri-
uretic factor has been demonstrated for a number of different
tissues (23-27).
Since an increase in cytosolic Ca is accepted as an
inhibitory signal for renin release from juxtaglomerular cells
(17, 18), we wanted to find out whether or not the effect of
ANP on renin release is initiated by cGMP, which leads
eventually to an increase in [Ca]i. However, we failed to
obtain any evidence for a stimulation of Ca influx into
juxtaglomerular cells by ANP or for an increase in [Ca]i as
measured by the quin-2 method. As a control, AII, that
inhibits renin release by increasing [Ca2+]i (8, 17, 18) in-
creased both the Ca influx (Table 2) and [Ca2+]i (Fig. 5).
From the entirety of our results we conclude that ANP
inhibits renin release from juxtaglomerular cells by a mech-
anism that, at least in isolatedjuxtaglomerular cells, does not
involve an increase in intracellular cGMP and that does not
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FiG. 6. Renin-releasing rate vs. cellular cGMP content. Renin-
releasing rate values are taken from Fig. 2, and cGMP levels are
taken from Fig. 3. Data are given as the percentage of the control
value, which was obtained in the absence ofANP and agents. o, ANP
without M&B 22948 and methylene blue; A, ANP with 1 mM M&B
22948; A, ANP with 10 jLM methylene blue; *, 1 ,uM sodium
nitroprusside.
Control 1748 ± 372 5778 ± 702 10,110 ± 1500
ANP 2385 ± 468 4539 ± 435 8,172 ± 675
AII 4014 ± 252 8280 ± 300 14,463 ± 750
Data are mean ± SEM of five experiments.
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alter the cellular Ca metabolism. Our results confirm the idea
proposed by Freeman et al. (28) that ANP has an important
physiological role in the control of renin release.
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